Old Web
English
Sign In
Acemap
>
Paper
>
Sorafenib combined with chemotherapy for patients with HER2 negative metastatic breast cancer: A Meta-analysis
Sorafenib combined with chemotherapy for patients with HER2 negative metastatic breast cancer: A Meta-analysis
2017
Xiao Chen Jia
Wen Jing Meng
Li Hong He
Yong Sheng Jia
Zhongsheng Tong
Keywords:
HER2 negative
Oncology
Randomized controlled trial
Meta-analysis
Sorafenib
Chemotherapy
Metastatic breast cancer
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]